About the Virus and Cancer Session
Viruses are microscopic 'organisms' that infect the cells of other animals and plants. Human cancer has been related to a number of viruses. When viruses cause an infection, their DNA spreads throughout the body, altering the genetic makeup of healthy cells and potentially leading to cancer. Viruses have been found to play a role in the biology of multistep oncogenesis and are linked to a number of cancer manifestations. Virus infections are thought to be responsible for 15–20 percent of all human cancers. Vaccines to help prevent specific human cancers have been developed as our knowledge of the role of viruses as a cause of cancer has expanded.
- Human tumor viruses
- Epstein-Barr virus (EBV)
- Human Papilloma Viruses (HPV)
- Hepatitis B virus (HBV)
- hepatitis C virus (HCV)
- Human immunodeficiency virus (HIV)
- Human herpes virus 8 (HHV-8)
- Other Oncogenic viruses
- Vaccines and Its Development
Topics Covered in Virus and Cancer
HPV-Driven Cancers
Hepatitis B & C
EBV-Associated Cancers
Retroviral Oncogenesis
Viral Oncoproteins
Prophylactic Vaccines
Related Scientific Sessions at CIOC 2027
Why Attend the Virus and Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Virus and Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Virus and Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Virus and Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Virus and Cancer Conference 2027 — FAQs
What is the Virus and Cancer track at CIOC 2027?
The Virus and Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Virus and Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Virus and Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Virus and Cancer are all welcome — whether presenting or attending.
Can I present my research in the Virus and Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Virus and Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Virus and Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.